business
AstraZeneca Broadens US Growth Push
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld. (Source: Bloomberg)
Read full story on Bloomberg Markets → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop